Cargando…

Sodium glucose co-transporter-2 inhibitors in intensive care unit patients with type 2 diabetes: a pilot case control study

BACKGROUND: Sodium glucose co-transporter-2 (SGLT2) inhibitors improve long-term cardiovascular and renal outcomes in individuals with type 2 diabetes. However, the safety of SGLT2 inhibitors in ICU patients with type 2 diabetes is uncertain. We aimed to perform a pilot study to assess the relations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mårtensson, Johan, Cutuli, Salvatore Lucio, Osawa, Eduardo A., Yanase, Fumitaka, Toh, Lisa, Cioccari, Luca, Luethi, Nora, Maeda, Akinori, Bellomo, Rinaldo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186281/ https://www.ncbi.nlm.nih.gov/pubmed/37194077 http://dx.doi.org/10.1186/s13054-023-04481-y

Ejemplares similares

Glycemic control and blood gas sampling frequency during continuous glucose monitoring in the intensive care unit: A before‐and‐after study
por: Mårtensson, Johan, et al.
Publicado: (2022)

Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply
por: Mårtensson, Johan, et al.
Publicado: (2023)

Prevalence of ketosis, ketonuria, and ketoacidosis during liberal glycemic control in critically ill patients with diabetes: an observational study
por: Luethi, Nora, et al.
Publicado: (2016)

The effect of insulin administration on c-peptide in critically ill patients with type 2 diabetes
por: Crisman, Marco, et al.
Publicado: (2017)

Haemodynamic effect of a 20% albumin fluid bolus in post-cardiac surgery patients
por: Cutuli, Salvatore L., et al.
Publicado: (2023)

Rapid 500 mL albumin bolus versus rapid 200 mL bolus followed by slower continuous infusion in post-cardiac surgery patients: a pilot before-and-after study
por: Yanase, Fumitaka, et al.
Publicado: (2023)

Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine
por: Cioccari, Luca, et al.
Publicado: (2020)

Temperature and haemodynamic effects of a 100 mL bolus of 20% albumin at room versus body temperature in cardiac surgery patients
por: Yanase, Fumitaka, et al.
Publicado: (2023)

Effects of changes in inspired oxygen fraction on urinary oxygen tension measurements
por: Osawa, Eduardo A., et al.
Publicado: (2022)

Cytokine and lipid metabolome effects of low-dose acetylsalicylic acid in critically ill patients with systemic inflammation: a pilot, feasibility, multicentre, randomised, placebo-controlled trial
por: Cioccari, Luca, et al.
Publicado: (2023)

Mega-dose sodium ascorbate: a pilot, single-dose, physiological effect, double-blind, randomized, controlled trial
por: Yanase, Fumitaka, et al.
Publicado: (2023)

The effect of dexmedetomidine on vasopressor requirements in patients with septic shock: a subgroup analysis of the Sedation Practice in Intensive Care Evaluation [SPICE III] Trial
por: Cioccari, Luca, et al.
Publicado: (2020)

Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis
por: Fujii, Tomoko, et al.
Publicado: (2021)

Accuracy of non-invasive body temperature measurement methods in adult patients admitted to the intensive care unit: a systematic review and meta-analysis
por: Cutuli, Salvatore L., et al.
Publicado: (2023)

Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis
por: Kalra, Sanjay, et al.
Publicado: (2015)

Sodium-dependent glucose transporter 1 and glucose transporter 2 mediate intestinal transport of quercetrin in Caco-2 cells
por: Li, Suyun, et al.
Publicado: (2020)

Trajectory of plasma syndecan‐1 and heparan sulphate during major surgery: A retrospective observational study
por: Weinberg, Laurence, et al.
Publicado: (2022)

Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment
por: D'Onofrio, Nunzia, et al.
Publicado: (2021)

Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications
por: Kobayashi, Minoru, et al.
Publicado: (2019)

Medication counselling with sodium glucose transporter 2 inhibitor therapy
por: Kalra, Sanjay, et al.
Publicado: (2014)

Harms and benefits of sodium-glucose co-transporter 2 inhibitors
por: Chesterman, Thomas, et al.
Publicado: (2020)

Sodium-Glucose Co-Transporter 2 Inhibitors and Fracture Risk
por: Erythropoulou-Kaltsidou, Anastasia, et al.
Publicado: (2019)

Sodium-glucose co-transporter 2 inhibitors beyond diabetes
por: Williams, Dimity L, et al.
Publicado: (2022)

Sodium glucose co-transport 2 inhibitors for gout treatment
por: Somagutta, Manoj Kumar Reddy, et al.
Publicado: (2022)

Sodium, Glucose and Dysregulated Glucagon Secretion: The Potential of Sodium Glucose Transporters
por: Armour, Sarah L., et al.
Publicado: (2022)

Serum Creatinine Levels and Nephrocheck® Values With and Without Correction for Urine Dilution-A Multicenter Observational Study
por: Hahn, Robert G., et al.
Publicado: (2022)

Continuous bladder urinary oxygen tension as a new tool to monitor medullary oxygenation in the critically ill
por: Hu, Raymond T., et al.
Publicado: (2022)

Sodium-Glucose Linked Transporter-2 Inhibitors in Chronic Kidney Disease
por: Zanoli, L., et al.
Publicado: (2015)

The Evolution of Sodium-Glucose Co-Transporter-2 Inhibitors in Heart Failure
por: Fadiran, Olusayo, et al.
Publicado: (2021)

Impact of Sodium–Glucose Co-Transporter 2 Inhibitors on Cardiac Protection
por: Wu, Victor Chien-Chia, et al.
Publicado: (2021)

Editorial: Sodium Glucose Co-Transporter 2 Inhibitors and Kidney Function
por: Van Raalte, Daniel H., et al.
Publicado: (2022)

Anti-Arrhythmic Effects of Sodium-Glucose Co-Transporter 2 Inhibitors
por: Jing, Yuling, et al.
Publicado: (2022)

Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Type 1 Diabetes Mellitus on Body Composition and Glucose Variabilities: Single-Arm, Exploratory Trial
por: Baba, Yusuke, et al.
Publicado: (2021)

Changes in SedLine-derived processed electroencephalographic parameters during hypothermia in patients undergoing cardiac surgery with cardiopulmonary bypass
por: Belletti, Alessandro, et al.
Publicado: (2023)

The obesity paradox and hypoglycemia in critically ill patients
por: Plečko, Drago, et al.
Publicado: (2021)

The Role of Sodium-Dependent Glucose Transporter 1 and Glucose Transporter 2 in the Absorption of Cyanidin-3-O-β-Glucoside in Caco-2 Cells
por: Zou, Tang-Bin, et al.
Publicado: (2014)

Role of sodium‐glucose transporters in glucose uptake of the intestine and kidney
por: Harada, Norio, et al.
Publicado: (2012)

Sodium glucose co transporter 2 inhibitors and Ramadan: Another string to the bow
por: Kelwade, Jayant, et al.
Publicado: (2014)

Sodium-glucose co-transporter-2 inhibitors and euglycemic ketoacidosis: Wisdom of hindsight
por: Singh, Awadhesh Kumar
Publicado: (2015)

Sodium glucose co-transporter-2 inhibitor: Patient safety and clinical importance
por: Senthilkumaran, Subramanian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0obqjfeub0r2qbk262csk7cvkm